Dr. Jackson has over 3 decades of healthcare industry experience working in hospitals, medical software, and commercial laboratory testing. He served seven years as an executive at ARUP Laboratories. He also spent two decades on faculty at the University of Utah School of Medicine, where he currently holds adjunct professor appointments in pathology and biomedical informatics.
Dr. Jackson completed his MD and MS degrees at the University of Utah, where he was a National Library of Medicine fellow in medical informatics. He completed residency in clinical pathology at Dartmouth-Hitchcock Medical Center, then worked for a Belgian medical software company, before joining ARUP and the University of Utah. He is active in the American Medical Informatics Association and the College of American Pathologists, where he leads workgroups studying ethical issues in healthcare technology.
Mark has held various positions in healthcare, including finance, corporate and clinical operations, investing, and growth strategy. He currently works in strategy and operations at Amae Health. He previously worked in healthcare investment banking at J.P. Morgan, healthcare investing at Red & Blue Ventures, strategy and operations at MD Ally, and as a search fund investor at Peterson Partners.
Mark completed his BS in Economics (summa cum laude) from the Wharton School at the University of Pennsylvania, where he concentrated in Entrepreneurship and Innovation.